Esperion Therapeutics Inc. (NASDAQ: ESPR) Hogging The Spotlight Today
Two Seas Capital LP recently announced the acquisition of new stake in Esperion Therapeutics Inc. (NASDAQ:ESPR). The institutional investor has increased its shareholding in the Healthcare company by 160.79% to 7.67 million shares with purchase of 4.73 million shares. This fresh investment now brings its stake to 6.75% valued currently at $10.2 million. In addition, […]
